SCOPUS 정보 검색 플랫폼

Volumn 56, Issue 3, 2002, Pages 152-158

Measurements of IL-6, soluble IL-6 receptor and soluble gp130 in sera of B-cell lymphoma patients. Does Viscum album treatment affect these parameters?

(2) Kovacs, E a Kuehn, J J b

a Society for Cancer Research (Switzerland)

b Lukas Clinic (Switzerland)

Author keywords

B cell lymphoma; IL 6; sgp130; sIL 6R; Viscum album

Indexed keywords

GLYCOPROTEIN GP 130; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; VISCUM ALBUM EXTRACT;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOMODULATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; SHORT COURSE THERAPY; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

EID: 0036228576 PISSN: 07533322 EISSN: None Source Type: Journal
DOI: 10.1016/S0753-3322(02)00165-8 Document Type: Article

Times cited : (10)

References (32)

1
- 0024360388
- The biology of interleukin-6
- (1989) Blood , vol.74 , pp. 1-10
- Kishimoto, T.¹

2
- 0029084805
- Interleukin-6 of cytokines gp130
- (1995) Blood , vol.86 , pp. 1243-1254
- Kishimoto, T.¹ Akira, S.² Narazaki, M.³ Taga, T.⁴

3
- 0027210354
- Parameters affecting the development of non-Hodgkin's lymphoma in patients with severe immuno-deficiency virus infection receiving antiretroviral therapy
- (1993) J Clin Oncol , vol.11 , pp. 1099-1107
- Pluda, J.M.¹ Venzon, D.J.² Tosato, G.³ Lietzan, J.⁴ Wyvill, X.⁵ Nelson, D.⁶

4
- 0025374736
- Expression of an exogenous interleukin-6 gene in human Epstein-Barr virus B cells confers growth advantage and tumorigenicity
- (1990) J Exp M , vol.172 , pp. 61-68
- Scala, G.¹ Quinto, J.² Ruocco, M.R.³ Arcucci, A.⁴ Mailardo, M.⁵ Laretto, P.⁶

5
- 0026745023
- Long-term consequence of interleukin-6 overexpressiom in transgenic mice
- (1992) DNA Cell Biol , pp. 587-592
- Woodrofe, G.¹ Muller, W.² Rother, D.³

6
- 0027421048
- Cytokines in malignant lymphomas: Review and prospective evaluation
- (1993) Human Pathol , vol.24 , pp. 1040-1057
- Hsu, S.M.¹ James, W.W.² Hsu, P.L.³ Aubrey, J.H.⁴

7
- 0024399987
- A possible autocrine role for interleukin-6 in two lymphoma cell lines
- (1989) Blood , vol.74 , pp. 798-804
- Yee, C.Y.¹ Blondi, A.² Wang, X.H.³ Iscove, N.N.⁴ Sousa J. de⁵ Aarden, L.A.⁶

8
- 0026485304
- Interleukin-6 and its receptor. A paradigm for cytokines
- (1992) Science , vol.258 , pp. 593-597
- Kishimoto, T.¹ Akira, S.² Taga, T.³

9
- 0026526873
- Interlukin-6 receptor and signals
- (1992) Chem Imuunol , vol.51 , pp. 181-204
- Taga, T.¹ Hibi, M.² Murakami, M.³ Saito, M.⁴ Yawata, H.⁵ Narazaki, M.⁶

10
- 0026782577
- Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acute- phase proteins
- (1992) J Immunol , vol.149 , pp. 2021-2025
- Mackiewicz, A.¹ Schooltink, H.² Heinrich, P.C.³ Rose-John, S.⁴

11
- 0031446516
- Major role of the soluble interleukin-6 /interleukin-6 receptor complex for the proliferation of interleukin-6-dependent human myeloma cell lines
- (1997) Eur J Immunol , vol.27 , pp. 3332-3340
- Gaillard, J.P.¹ Liautard, J.² Klein, B.³ Brochier, J.⁴

12
- 0027293104
- Soluble form of interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130
- (1993) Blood , vol.82 , pp. 1120-1128
- Narazaki, M.¹ Yasukawa, K.² Saito, T.³ Oshugi, Y.⁴ Fukui, H.⁵ Koishihara, Y.⁶

13
- 0028893151
- Clinical implications of cytokine and soluble receptor measurements in patients with newly-diagnosed aggressive non Hodgkin's lymphoma
- (1995) Eur J Haematol , vol.54 , pp. 9-17
- Stasi, R.¹ Zinzani, P.L.² Galieni, P.³ Lauta, V.M.⁴ Damasio, E.⁵ Dispensa, E.⁶

14
- 0028955069
- Diagnostic value of serum IL-6 level in monoclonal gammopathies
- (1995) Br J Haematol , vol.89 , pp. 243-249
- DuVillard, L.¹ Guiguet, M.² Casasnovas, R.O.³ Caillot, D.⁴ Monnier Zeller, V.⁵ Bernard, A.⁶

15
- 0027278569
- Serum interleukin-6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms
- (1993) Cancer Res , vol.53 , pp. 2118-2122
- Kurzrock, E.¹ Redman, J.² Cabanillas, F.³ Jones, D.⁴ Rothberg, J.⁵ Talpaz, M.⁶

16
- 0031046182
- Clinical correlates of elevated serum levels of interleukin-6 in patients with untreated Hodgkin's disease
- (1997) Am J M , vol.102 , pp. 21-28
- Seymour, J.F.¹ Talpaz, M.² Hagemeister, F.B.³ Cabanillas, F.⁴ Kurzrock, E.⁵

17
- 0032423450
- C-reactive protein serum level is a valuable and simple prognostic marker in non-Hodgkin's lymphoma
- (1998) Leuk Lymph , vol.31 , pp. 351-357
- Legouffe, E.¹ Rodriguez, C.² Picot, M.C.³ Richard, B.⁴ Klein, B.⁵ Rossi, J.F.⁶

18
- 0028883640
- Detection of membrane and soluble interleukin-6 receptor in lymphoid malignancies
- (1995) Br J Haematol , vol.91 , pp. 871-877
- Lavabre-Bertrand, T.¹ Exbrayat, C.² Liautard, J.³ Gaillard, J.P.⁴ Baskevitch, P.P.⁵ Poujol, N.⁶

19
- 0030959906
- Serum levels of soluble IL-6 receptor in multiple myeloma as indicator of disease activity
- (1997) Acta Haematologica , vol.97 , pp. 191-195
- Papadaki, H.¹ Kyriakou, D.² Foudoulakis, A.³ Markidou, F.⁴ Alexandrakis, M.⁵ Eliopoulos, G.⁶

20
- 0032901005
- Circulating IL-6-type cytokines and sIL-6R in patients with multiple myeloma
- (1999) Br J Haematol , vol.105 , pp. 412-419
- Wierzbowska, A.¹ Urbanska-Rys, H.² Robak, T.³

21
- 0032466601
- Blocking interleukin-6 activity with chimeric anti-IL-6 monoclonal antibodies in multiple myeloma: Effects on soluble IL-6 receptor and soluble gp130
- (1998) Leuk Lymphoma , vol.31 , pp. 551-558
- Van Zaanen, H.C.¹ Lokhorst, H.M.² Aarden, L.A.³ Rensink, H.J.⁴ Warnaar, S.O.⁵ Van Oers, M.H.⁶

22
- 0033856293
- Serum levels of IL-12 and the production of IFN-gamma, IL-2 and IL-4 by peripheral blood mononuclear cells (PBMC) in cancer patients treated with Viscum album extract
- (2000) Biomed & Pharmacother , vol.54 , pp. 305-310
- Kovacs, E.¹

23
- 0024598468
- Interleukin-6 gene expression in normal and neoplastic B cells
- (1989) J Clin Invest , vol.83 , pp. 1512-1518
- Freeman, G.J.¹ Freeman, A.S.² Rabinowe, S.N.³ Segil, J.M.⁴ Horowitz, J.⁵ Rosen, K.⁶

24
- 0025853227
- Serum levels of interleukin-6 in multiple myeloma and other hematological disorders: Correlation with disease activity and other prognostic parameters
- (1991) Ann Hematol , vol.62 , pp. 54-58
- Nachbaur, D.M.¹ Herold, M.² Maneschg, A.³ Huber, H.⁴

25
- 0031862153
- Production and effects of interleukin-6 and other cytokines in patients with non-Hodgkin's lymphoma
- (1997) Leuk Lymph , vol.29 , pp. 71-79
- Kato, H.¹ Kinoshita, T.² Suzuki, S.³ Nagasaka, T.⁴ Hatano, S.⁵ Murate, T.⁶

26
- 0026763476
- Interleukin-6 levels in the plasma of patients with lymphoma
- (1992) Leuk Lymph , vol.7 , pp. 123-129
- Yee, C.¹ Sutcliffe, S.² Messner, H.A.³ Minden, M.D.⁴

27
- 0033193042
- Immunomodulatory mistletoe therapy by lectin standardisation: A double-edged sword?
- (1999) Versicherungsmedizin , vol.51 , pp. 128-136
- Gabius, S.¹ Gabius, H.J.²

28
- 0028796711
- Soluble interleukin-6 receptors in inflammatory bowel disease: Relation to circulating interleukin-6
- (1995) Gut , vol.36 , pp. 45-49
- Mitsuyama, K.¹ Toyonaga, A.² Sasaki, E.³ Ishida, O.⁴ Tsurata, O.⁵ Harada, K.⁶

29
- 0032868099
- Interleukin-6 receptor signaling. II. Bio-availability of interleukin-6 in serum
- (1999) Eur Cytokine Netw , vol.10 , pp. 557-643
- Gaillard, J.P.¹ Fugnière, M.² Tresca, J.P.³ Mani, J.C.⁴ Klein, B.⁵ Brochier, J.⁶

30
- 0038739858
- Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses
- (1998) J Immunol , vol.161 , pp. 6347-8355
- Müller-Newen, G.¹ Käster, A.² Hemmann, U.³ Keul, R.⁴ Horsten, U.⁵ Martens, A.⁶

31
- 0035160256
- Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor trenssignaling responses
- (2001) Eur J Biochem , vol.268 , pp. 150-167
- Jostock, T.¹ Mullberg, J.² Ozbek, S.³ Atreya, R.⁴ Blinn, G.⁵ Voltz, N.⁶

32
- 0033501137
- Serum levels of IL-6 type cytokines and soluble IL-6 receptors in active B-cell chronic lymphocytic leukemia and in cladribine induced remission
- (1999) Mediators Inflamm , vol.8 , pp. 277-286
- Robak, T.¹ Wierzbowska, A.S.² Blasinska-Morawiec, M.³ Koreyka, A.⁴ Blonski, J.Z.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.